Warning: The NCBI web site requires JavaScript to function. more...
Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y, Hoang-Vu C, Hombach-Klonisch S.
Breast Cancer Res. 2008;10(4):R71. Epub 2008 Aug 21.
Related citations
Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells.
Ann N Y Acad Sci. 2005 May;1041:462-9.
The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.
Int J Mol Med. 2007 Oct;20(4):605-11.
Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
Radestock Y, Willing C, Kehlen A, Hoang-Vu C, Hombach-Klonisch S.
Mol Cancer Res. 2010 Apr;8(4):494-506. Epub 2010 Mar 23.
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.
Breast Cancer Res. 2007;9(6):R76.
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.
Breast Cancer Res. 2008;10(2):R22. Epub 2008 Mar 7.
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE.
Clin Cancer Res. 2005 Aug 15;11(16):6012-9.
Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer.
Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE, Jiang WG.
Breast Cancer Res. 2005;7(4):R402-10. Epub 2005 Apr 4.
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.
Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X.
J Exp Clin Cancer Res. 2010 Jul 10;29:92.
Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M, Yao J, Yu D.
Cancer Res. 1997 Mar 15;57(6):1199-205.
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P.
Breast Cancer Res. 2005;7(4):R422-35. Epub 2005 Apr 4.
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G, Reule M, Tschirschmann M, Dankert N, Stout-Weider K, Lauster R, Schrock E, Mennerich D, Duda GN, Lehmann KE.
BMC Cancer. 2007 Jan 17;7:12.
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.
Mol Cancer. 2009 Oct 1;8:81.
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
Verjans E, Noetzel E, Bektas N, Schütz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J.
BMC Cancer. 2009 Jul 14;9:230.
The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.
Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG.
Int J Oncol. 2008 Sep;33(3):585-93.
CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS, Wang MY, Wu SN, Su JL, Hong CC, Chuang SE, Chen MW, Hua KT, Wu YL, Cha ST, Babu MS, Chen CN, Lee PH, Chang KJ, Kuo ML.
J Cell Sci. 2007 Jun 15;120(Pt 12):2053-65.
TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL, Williams BJ, Carroll JL, Daves LK, Cardelli JA.
Breast Cancer Res Treat. 2009 Sep;117(1):31-44. Epub 2008 Sep 12.
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE.
Breast Cancer Res. 2009;11(3):R32. Epub 2009 May 27.
Estrogen and TCDD influence RLN2 gene activity in estrogen receptor-positive human breast cancer cells.
Kietz S, Feng S, Agoulnik A, Hombach-Klonisch S.
Ann N Y Acad Sci. 2009 Apr;1160:367-73.
[Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
Wang Z, Liu Q, Chen Q, Zhu R, Zhu HG.
Zhonghua Bing Li Xue Za Zhi. 2006 Jun;35(6):333-8. Chinese.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on